We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$248M
AUM Growth
-$54.7M
Cap. Flow
-$53.1M
Cap. Flow %
-21.45%
Top 10 Hldgs %
14.37%
Holding
315
New
136
Increased
18
Reduced
93
Closed
58

Sector Composition

Rank Sector Weight
1 Healthcare 24.81%
2 Technology 18.88%
3 Industrials 12.19%
4 Consumer Discretionary 11.96%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
251
Danaher
DHR
$141B
$31K 0.01%
+451
New +$31.3K
AKAO
252
DELISTED
Achaogen Inc
AKAO
$26K 0.01%
+2,000
New +$13.7K
SLB icon
253
SLB Ltd
SLB
$76.5B
$21K 0.01%
+250
New +$20.5K
ACRS icon
254
Aclaris Therapeutics
ACRS
$851M
$20K 0.01%
+750
New +$19.1K
MT icon
255
ArcelorMittal
MT
$55.2B
$20K 0.01%
+893
New +$19K
TRVN
256
DELISTED
Trevena, Inc.
TRVN
$15K 0.01%
4
-218
-98% -$779K
ANTH
257
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$10K ﹤0.01%
+1,875
New +$32.5K
ALB icon
258
Albemarle
ALB
$14.8B
-3,340
Closed -$286K
ALNY icon
259
Alnylam Pharmaceuticals
ALNY
$28.9B
-6,760
Closed -$458K
AMGN icon
260
Amgen
AMGN
$219B
-125
Closed -$21K
ARMK icon
261
Aramark
ARMK
$14.8B
-148,915
Closed -$4.09M
AU icon
262
AngloGold Ashanti
AU
$44.3B
-86,100
Closed -$1.37M
AX icon
263
Axos Financial
AX
$5.78B
-40,000
Closed -$896K
AYI icon
264
Acuity Brands
AYI
$10.7B
-12,670
Closed -$3.35M
BALL icon
265
Ball Corp
BALL
$16.7B
-27,440
Closed -$1.12M
BMY icon
266
Bristol-Myers Squibb
BMY
$131B
-9,060
Closed -$488K
BR icon
267
Broadridge
BR
$18.8B
-22,000
Closed -$1.49M
CASY icon
268
Casey's General Stores
CASY
$30.8B
-15,350
Closed -$1.84M
CERS icon
269
Cerus
CERS
$468M
-103,530
Closed -$643K
CEVA icon
270
CEVA Inc
CEVA
$992M
-25,000
Closed -$877K
CYH icon
271
Community Health Systems
CYH
$416M
-54,320
Closed -$627K
DLTH icon
272
Duluth Holdings
DLTH
$158M
-19,000
Closed -$504K
DVN icon
273
Devon Energy
DVN
$47.4B
-3,360
Closed -$148K
DXCM icon
274
DexCom
DXCM
$31.3B
-62,000
Closed -$1.36M
FIVN icon
275
FIVE9
FIVN
$2.17B
-25,000
Closed -$392K

Similar funds

Turner Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Turner Investments held 315 positions worth $248M, down 18% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Turner Investments withdrew a net $53.1M in Q4 2016, closing 58 positions and reducing 93 holdings. Its most notable exit was Aramark, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Idexx Laboratories worth $3.17M.

  • Turner Investments's largest Q4 2016 buy was Idexx Laboratories: 27,000 shares worth $3.17M.
  • Turner Investments added most to bluebird bio in Q4 2016, an estimated $1.26M increase.
  • Turner Investments's biggest Q4 2016 reduction was Paramount Global Class B, cutting an estimated $5.27M.
  • Turner Investments fully exited Aramark in Q4 2016, selling an estimated $4.09M.
  • Turner Investments's ten largest holdings make up 14% of its $248M portfolio in Q4 2016.
  • Turner Investments opened 136 new positions and closed 58 in Q4 2016.
  • Turner Investments's portfolio value fell 18% quarter-over-quarter to $248M.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.